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Background: Approximately 20–30% of patients with cancer experience a clinically relevant level of emotional
distress in response to disease and treatment. This in itself is alarming but it is even more problematic because it is
often difficult for physicians and nurses to identify cancer patients who experience clinically relevant levels of
anxiety and depression symptoms. This can result in persistent distress and can cause human suffering as well as
costs for individuals and to the community.
Methods: Applying a multi-disciplinary and design-oriented approach aimed at attaining new evidence-based
knowledge in basic and applied psychosocial oncology, this protocol will evaluate an intervention to be
implemented in clinical practice to reduce cancer patient anxiety and depression. A prospective randomized design
will be used.
The overarching goal of the intervention is to promote psychosocial health among patients suffering from cancer
by means of self-help programmes delivered via an Internet platform. Another goal is to reduce costs for
individuals and society, caused by emotional distress in response to cancer.
Following screening to detect levels of patient distress, patients will be randomized to standard care or a stepped
care intervention. For patients randomized to the intervention, step 1 will consist of self-help material, a chat forum
where participants will be able to communicate with each other, and a Frequently Asked Questions (FAQ) section
where they can ask questions and get answers from an expert. Patients in the intervention group who still report
symptoms of anxiety or depression after access to step 1 will be offered step 2, which will consist of cognitive
behavioral therapy (CBT) administered by a personal therapist. The primary end point of the study is patients’ levels
of anxiety and depression, evaluated longitudinally during and after the intervention.
Discussion: There is a lack of controlled studies of the psychological and behavioral processes involved in this type
of intervention for anxiety and depressive disorders. Since anxiety and depressive symptoms are relatively common
in patients with cancer and the availability of adequate support efforts is limited, there is a need to develop
evidence-based stepped care for patients with cancer, to be delivered via the Internet.
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The need to identify patients with clinical levels
of distress
In Sweden approximately 55,000 persons were diagnosed
with cancer in 2010 [1]. Research has shown that a large
proportion of patients with cancer have the ability to
handle the mental strain that the disease can cause [2-4].
However, 20–30% develop anxiety and depression symp-
toms [5-7]. There is a need for enhanced psychosocial
support for this group in order to prevent persistent psy-
chological distress [8]. Patients with incurable disease re-
port higher levels of anxiety and depression compared
with patients who can be cured [9]. Several studies have
also shown a correlation between cancer patients’ and
their family’s levels of psychological distress [10].
Also, a lack of social network and a low socio-economic
status, with a low educational level, low income and un-
favourable working conditions, can have a negative impact
on cancer patients’ psychological and physical wellbeing as
well as on disease progression [11,12]. Such factors should
be included as potential moderators in studies of interven-
tions aimed at reducing psychological problems.
Screening to identify patients needing support
There is a need to identify cancer patients who might
need extra psychosocial support. It can be difficult to
identify psychological problems as they often manifest in
the same way as disease-related symptoms, e.g. with fa-
tigue and impaired functioning. Several screening ques-
tionnaires are available to identify patients at risk of
developing psychological disorders [13]. General screen-
ing of patients may identify patients who have an in-
creased need for psychosocial support and psychological
treatment [14]. Internet-based screening may be one way
to increase access and automate the calculations that
are often necessary when screening for psychiatric dis-
orders. Development of interactive computerized systems
and Internet-based research into screening with established
instruments is an important part of the methodological
development.
Interactive support and cognitive behavioral therapy
During the last decades, computerized interactive support
(IS) efforts that combine health information with support
for behaviour change, social support such as discussion for-
ums, and support to make decisions have been developed
for patients with chronic diseases. A Cochrane review [15]
based on 24 randomized controlled trials in chronic disease
concluded that such efforts lead to increased knowledge,
positive changes in behaviour, a sense of increased social
support, better health, improved functional status and
fewer symptoms. The conclusions are that this type of sup-
port seems efficient, but more studies are needed to con-
firm that these results also apply to cancer.Studies that investigate the effects of web-based discus-
sion forums in which patients share information and dis-
cuss experiences show conflicting results. One randomized
study concluded that an online discussion forum moder-
ated by health professionals can lead to decreased psycho-
logical problems in women with breast cancer [16]. These
findings were contradicted by the results of a recently pub-
lished randomized trial in mixed diagnoses that did not
show any positive effects of a non-moderated web-based
discussion forum, but rather, a tendency towards poorer
psychological wellbeing in the intervention group com-
pared with the control group [17].
Using the Internet to deliver cognitive behavioral therapy
(CBT) has many advantages. The Internet has become
more integrated into the daily lives of a big part of the
population and offers new opportunities for interventions.
During the past decade, using Internet-delivered interven-
tions has become more common and, according to a
meta-analysis including twelve randomized controlled tri-
als, Internet-based CBT has advantages over traditional
CBT for both clients and health care providers’ [18]. The
treatment can be obtained at any time and place and par-
ticipants can use it at their own pace and review the mater-
ial as often as desired. The level of therapist involvement
can be adjusted to the actual need and it may be possible
to reduce the therapist time while maintaining efficacy. It
may also be possible to reach people through the Internet
who might otherwise not receive treatment for their prob-
lems. According to the same meta-analysis, studies show
that Internet-delivered CBT is as effective as traditional, in-
dividual, face-to-face CBT [18]. However, there is need for
more, and larger, studies to determine the effects of
Internet-based CBT for different types of symptoms in pa-
tients with cancer.
There is also a need to understand more about the actual
uptake of support. A large proportion of cancer patients
with psychological problems do not use available support-
ive psychosocial resources [19]. According to one study,
approximately 30% of patients with cancer who reported
symptoms of anxiety or depression declined support [20].
Among the motives reported for refraining from making
use of the support offered were a long distance from the
clinic and that they already had an established support
contact. For patients living a long distance from the clinic,
Internet-delivered interventions can be a suitable solution.
Stepped care, a promising route to more individual
uptake of support
Stepped care means that care is given with different inten-
sity for different individuals. Treatment effects are repeat-
edly evaluated and patients who do not respond to one
level of support are transferred to another level and receive
more intensive support [21]. Stepped care has successfully
been used for treatment of anxiety and depression in the
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stepped care for psychological problems may comprise
education about common symptoms and effective self-help
strategies (psycho-education), counselling, and support
from other patients. A more intensive treatment level may
comprise individual CBT. Stepped care can improve access
to support and psychological treatment in a cost-effective
manner, particularly if the method is provided via the
Internet [18,21,24]. There are virtually no studies of the
health economic aspects of interventions aimed at redu-
cing psychological distress in patients with cancer. A few
studies suggest that treatment with CBT for anxiety, de-
pression and dysfunctional fear of recurrence of cancer is a
cost-effective alternative to other methods of treatment
[25,26]. It is important to examine the health economic as-
pects of this type of intervention to determine whether it is
cost-effective to implement in routine care.
Aim
The aim of the planned study is to investigate the effects
of an Internet-based stepped care model, comprising IS
and CBT, on levels of anxiety, depression and health-
related quality of life in adults with cancer and with
symptoms of depression and/or anxiety. Further, the aim
is to evaluate the health economic aspects of the inter-
vention. Stepped care will be compared with standard
care in a randomized study design.
The main research questions
Primary research question
 Do participants who receive Internet-based stepped
care report lower levels of anxiety and/or depressive
symptoms at 10 months after randomization
compared with participants receiving standard care?
See details under “Statistical power” below.
Secondary research questions
 Will participants who report anxiety and/or
depression symptoms at diagnosis and who receive
Internet-based stepped care report lower levels of
anxiety, depression, post- traumatic stress and
improved health-related quality of life in the short
and long term (≤24 months after diagnosis)?
 Is Internet-based stepped care cost-effective or at
least cost-neutral compared with standard care at 10
and 24 months after diagnosis?
 To what extent do participants use the IS skills and
strategies suggested for countering symptoms?
Methods
The present project is part of the Uppsala University psy-
chosocial care programme (U-CARE), an interdisciplinaryprogramme which is being conducted in close collabor-
ation between researchers in clinical psychology, informa-
tion systems, nursing sciences, medical sciences and
economics. An Internet platform (the U-CARE portal) has
been developed within the U-CARE programme. The U-
CARE portal is used for interventions and data collection
in all projects undertaken within the framework of the re-
search programme.
Design
The present project comprises a prospective randomized
controlled trial where stepped care will be compared
with standard care. Figure 1 provides an outline of the
trial design.
Participants
Inclusion of patients will start in March 2013 and will con-
tinue for approximately 18 months. Patients with newly
(within 6 months) diagnosed early-stage breast, prostate or
colorectal cancer as well as patients with recurrence of
colorectal cancer (within 6 months of diagnosis) at three
hospitals in Sweden will be asked to participate in the
study. Exclusion criteria are inability to read and under-
stand Swedish, cognitive disability (such as dementia or
psychosis), a constant need of care (Karnofsky score <40),
short expected survival (<3 months), severe depression or
suicide risk with regard to answers on the Montgomery-
Åsberg Depression Rating Scale – Self-Report (MADRS-S)
measure (see “Data collection” below), and participation
in a competing clinical trial including prostate cancer pa-
tients receiving radiotherapy. In our previous randomized
controlled intervention study on quality of life aspects,
approximately 70% of eligible patients agreed to partici-
pate, and about 70% of these completed participation [2].
There is a risk that a greater proportion of patients will
refuse to take part in the present project since it requires
access to the Internet, a mobile phone and some com-
puter skills.
Statistical power
The main outcome measure is the Hospital Anxiety and
Depression Scale (HADS) [27]. It consists of 14 questions
divided into one subscale for anxiety symptoms (seven
questions) and one for depressive symptoms (seven ques-
tions). Both are 21-point scales. Values >7 points on any
of the subscales indicate mild anxiety or depression.
Values > 10 points indicate clinically significant levels of
anxiety and depressive symptoms. A change of at least
20% on the HADS is considered to be a clinically relevant
change [28]. In one previous study of patients with >7
points cut-off on any of the HADS subscales, the mean
score for anxiety was 10 and for depression, 8 [6]. To
achieve 80% statistical power (alpha = 0.05) needed to de-

































Figure 1 Flowchart of the study. ICBT = Internet-based cognitive behavioral therapy.
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required in each of the intervention and control groups.
Based on experience from previous intervention studies,
we estimate that approximately 30% of study participants
will not complete the data collection. This means that we
need to include at least 95 patients in each group. For the
present study, approximately 1,300 patients need to be
enrolled, >300 of whom are likely to have anxiety or
depression symptoms, >200 of whom can be expected to
complete the study.
Patients with <7 points on any of the subscales will be
allocated to a reference group and answer questionnaires
at baseline and at three observation points during the
time of the intervention. They will answer questionnaires
that measure anxiety, depression and health-related quality
of life.
Randomization
Participants with anxiety and/or depressive symptoms
(>7 on any of the HADS subscales) will be randomized
to either Internet-based stepped care or standard care.
Randomization will be stratified for curable/non-curable
disease and will be done in blocks.
Intervention – stepped care
The intervention involves providing stepped care treat-
ment, which consists of IS (step 1) followed by CBT
(step 2). All participants randomized to the intervention
group will have access to step 1 from randomization and
throughout the study period (24 months). Patients with
persistent symptoms of anxiety or depression (>7 on anyof the HADS subscales) at 1, 4 or 7 months after inclusion
will be offered step 2 and will be able to choose CBT or to
have continued access to IS at step 1 only.
Interactive support – step 1
Step 1 provides information about the disease and about
common symptoms and strategies to improve health
and prevent physical and psychological problems such as
anxiety, sleeping problems, adverse effects of cancer
therapy, cancer-related fatigue and pain. Examples of
strategies provided include relaxation techniques, phys-
ical exercise, good diet and sleeping habits and positive
activities. Step 1 consists of web-based material including
psycho-education and teaching of simple intervention
strategies. It also includes a Frequently Asked Questions
(FAQ) database where participants can read questions
from other participants as well as ask their own ques-
tions. A moderated discussion forum is provided for dis-
cussion of various symptoms and how they may be
countered, as well as other issues related to the disease or
treatment. It is also possible to keep a personal diary and/
or write a blog. Doctoral students who are trained nurses
have the primary responsibility to answer questions and
moderate the discussion forums under the supervision of a
psychologist. The moderators may also contact oncologists
involved in the study, specialist nurses, a social worker and
a dietician if there is need for specialist knowledge or input.
Participants who do not log in will be reminded to do so
by short messaging service (SMS) or e-mail and offered
help with logging in to the portal. The material is collected
in a digital library and includes audio and video lectures,
Table 1 Summary of the study’s instruments and the
observation points at which they will be used
Instrument Observation points
HADS At baseline and at 1, 4, 7, 10, 18
and 24 months
MADRS-S At baseline and at 10 months
STAI-S At baseline and at 10 months
ESSI At baseline
NLEs At baseline
EROS At baseline and at 10 months
PCL-C At baseline and at 10, 18 and
24 months
EORTC QLQ-C30 At baseline and at 1, 4, 7, 10, 18
and 24 months
EORTC QLQ-BR231 At baseline and at 1, 4, 7, 10, 18
and 24 months
EORTC QLQ-PR251 At baseline and at 1, 4, 7, 10, 18
and 24 months
EORTC QLQ-CR291 At baseline and at 1, 4, 7, 10, 18
and 24 months
FACIT-F At baseline and at 1, 4, 7, 10, 18
and 24 months
ISI At baseline and at 1, 4, 7, 10, 18
and 24 months
PTGI-SF At 10 months
Health economic questionnaire At 1, 4, 7, 10, 18 and 24 months
EQ-5D At 2 weeks and 1, 4, 7, 10, 18
and 24 months
Patient satisfaction questionnaire At 1, 4 and 10 months
Internet use questionnaire At 1, 4, 7, 10, 18 and 24 months
Knowledge and strategies
questionnaire
At 2 weeks and 1 and 10 months
EORTC QLQ European Organization for Research and Treatment of Cancer
(EORTC) Quality of Life Questionnaire, EQ-5D Euroqol 5D, EROS Environmental
Reward Observation Scale, ESSI Enriched Social Support Inventory, FACIT-F
Functional Assessment of Cancer Therapy: Fatigue, HADS Hospital Anxiety and
Depression Scale, ISI Insomnia Severity Index, MADRS-S Montgomery-Åsberg
Depression Rating Scale – Self-Report, NLEs Negative Life Events questionnaire,
PCL-C Post-Traumatic Stress Disorder (PTSD) Checklist – civilian version,
PTGI-SF Post-Traumatic Growth Inventory, Short Form, QLQ-Br25 Quality of Life
Questionnaire with diagnosis-specific modules for breast cancer, QLQ-C30
Quality of Life Questionnaire, Core 30, QLQ-CR29 Quality of Life Questionnaire with
diagnosis-specific modules for colorectal cancer, QLQ-PR25 Quality of Life
Questionnaire with diagnosis-specific modules for prostate cancer, STAI-S
State-Trait Anxiety Inventory – State anxiety subscale.
1 = if appropriate.
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suggested reading. The content of the library is divided
into modules divided into topics, such as disease treat-
ment, health promotion, and common symptoms with
strategies for alleviation.
Representatives from patient organizations have con-
tributed to the design of step 1 of the intervention and
will participate in the discussion forum. This is because
there must be a relevant content in the discussion forum
when the first participants in the randomized controlled
trial begin using step 1. Representatives from patient or-
ganizations have also participated in tests regarding the
usability of the portal.
Cognitive behavior therapy – step 2
The Internet-based CBT in step 2 consists of stand-
ard CBT programmes for psychological problems. At
the beginning of treatment in step 2, participants will
receive a list of treatment modules regarding sleeping
problems, depression, etc and will be able to choose the
problem area/s they want to work with. The treatment is
highly structured. It follows established treatment man-
uals and includes exercises, assignments, self-monitoring
and weekly contact with a psychologist over the Internet.
A participant who does not follow the treatment plan is
reminded and encouraged to participate in the programme;
however, it is not mandatory to complete the treatment. In
total, step 2 consists of 10 weeks of intervention followed
by evaluation. Participants cannot repeat step 2. After
finishing step 2, participants have, however, access to the
material for the remainder of the study period.
Standard care
Standard care includes the basic information always
provided in routine health care, i.e. information about
the disease, the treatment that the patient will undergo,
possible side effects of the treatment, and what the pa-
tient can do to prevent and relieve symptoms and side
effects. Information on existing psychosocial support
is given to all patients by the physician or nurse in
charge. Psychosocial support activities include, on an
as-needed basis, the opportunity to talk to a social
counsellor or deacon/priest from the hospital church
and, occasionally, to support groups. If the need for
help with anxiety or depression is identified, patients
are encouraged to raise the problems with the phys-
ician responsible for the treatment, for further action
which might include pharmacological treatment of anx-
iety and depression, general support and referral to men-
tal health care.
Data collection
All patient-reported data will be collected through the U-
CARE platform. Well-known questionnaires with goodpsychometric properties will be used. Table 1 presents an
outline of questionnaires and observation points.
Anxiety and depression
The HADS [27] is used as a short screening instrument for
symptoms of anxiety and depression and for evaluating the
effects of the Internet-based stepped care. The HADS has
been used extensively both clinically and in cancer care re-
search and has good psychometric properties [29]. It has
been successfully administered via the Internet in other
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instrument for severe depression and/or suicide risk. It has
shown good ability to identify depressive symptoms [33]
and it will be used in this study to measure symptoms of
depression at inclusion and 10 months after inclusion. The
MADRS-S consists of nine questions with response scores
of 0–60 points, where values >30 points are considered to
indicate severe depression. The MADRS-S includes an
item connected with suicidal ideation, where scoring ≥3 on
this item is considered to be an indication of present sui-
cide risk. Participants scoring ≥3 on this item will be
contacted by one of the psychologists of the project and of-
fered adequate help. The Spielberger State-Trait Anxiety
Inventory – State anxiety subscale (STAI-S) [34] will be
used to measure anxiety at inclusion and 10 months after
inclusion. It consists of 20 questions and has good ability
to identify anxiety problems in both younger and older pa-
tients [35]. The STAI-S has been administered via the
Internet in research.
Post-traumatic stress and health-related quality of life
Post-traumatic stress disorder (PTSD) is measured using
the PTSD Checklist – civilian version (PCL-C) [36].
The PCL-C consists of 17 questions regarding trauma-
related anxiety symptoms. The questions correspond to
the diagnostic criteria specified for PTSD in the Diagnostic
and Statistical Manual of Mental Disorders, 4th edition
(DSM-IV) [37].
Health-related quality of life will be measured using
the European Organization for Research and Treatment
of Cancer (EORTC) Quality of Life Questionnaire, Core 30
(QLQ-C30) [38], and EORTC diagnosis-specific modules
for breast cancer (QLQ-BR23) [39], prostate cancer (QLQ-
PR25) [40] and colorectal cancer (QLQ-CR29) [41]. The
diagnosis-specific modules are used as supplements to the
QLQ-C30. They are all widely used in research projects in
cancer care. The core questionnaire, QLQ-C30, consists of
30 questions measuring global health status, quality of life,
five features (physical, emotional, cognitive, social, and role
functioning) and nine symptoms that are common to
all cancers, regardless of diagnosis. The diagnosis-specific
modules consists of 23 (QLQ-BR23), 25 (QLQ-PR25) and
29 (QLQ-CR29) questions measuring functions and symp-
toms that are specific to each diagnostic group.
Health economy
For the health economic evaluation, data will be collected
from several registers, primarily the longitudinal integra-
tion database for health insurance and labour market stud-
ies (LISA) or LISA’s original records, the patient register,
the multi-generation register, the cancer register, the pa-
tient register and the pharmaceutical registry as well as
other records that may be relevant. Data on health-related
expenses not covered by the registry data will be collectedvia a project-specific health economic survey (HES). The
EuroQol EQ-5D [42] will be used for calculation of life-
adjusted life years.
Medical and socio-demographic background data
Information about the patients’ medical background,
treatment and cancer-related outcome will be obtained
from the diagnosis-specific Regional Oncology Centre
records and from the medical records. Details about the
psychosocial support provided within the standard care
group will be collected via the HES where the patients
will be asked to report any contact with the social worker,
psychiatrist, psychologist, psychotherapist or the hospital
church. Demographic data will be obtained via project-
specific questions.
Internet use
Data on the intervention and control groups’ Internet use
related to their cancer disease will be collected through
project-specific questions.
Knowledge on and use of strategies to counteract
symptoms
Knowledge of the disease, common symptoms and strat-
egies to counter symptoms will be examined in a project-
specific survey. The survey will include questions about
perceived knowledge and whether and to what extent the
patients have used, and are using, the proposed strategies
to counter current symptoms. In addition, data on each
study participant’s use of educational materials, activity in
the “Questions and Answers (Q&A)” section, posts in dis-
cussion forums and notes in the diary will be logged in the
U-CARE portal.
Observation points
Data will be collected at baseline and at 1, 4, 7, 10, 18
and 24 months after inclusion. For the health economic
evaluation, economic data will be collected at the above
time points. Data on knowledge and use of strategies as
well as health economic data (EQ-5D) will be collected
also 2 weeks after inclusion.
Procedure
Pilot study
A pilot study will be carried out using the same proce-
dures and design as in the main study (see below). An
evaluation will be made after randomization of 20 partic-
ipants to the study. The evaluation will be made with re-
spect to inclusion frequency, participants’ activity in
steps 1 and 2 and the proportion of patients with per-
sistent anxiety and depressive symptoms 1 month after
inclusion. If the evaluation does not give rise to changes
in the study design or procedures, the pilot study will
seamlessly proceed to the main study.
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Eligible patients at the oncology, urology and surgery
clinic will be identified and asked for informed consent
at a regular visit to the clinic within 6 months after ini-
tial diagnosis or detection of disease relapse.
First, participants will be asked to answer all the
study’s questionnaires via the U-CARE portal. Patients
with severe depression or suicide risk (as measured by
the MADRS-S, see “Data collection”) at inclusion or at
the 10-month measurement will be excluded from the
project and contacted via telephone by a project staff
psychologist. Likewise, patients will be contacted by a
psychologist if there is reason to believe that they have
severe depression or are suicidal according to what they
write in the forum or diary or what they post on the chat.
Participants in the intervention group will have access to
IS immediately after randomization. Both the intervention
and the control group will receive the psychosocial support
as part of the standard care at their respective clinic. Both
groups will answer a set of questionnaires at observation
points described in Table 1. The reference group will an-
swer a set of questionnaires at some of the observation
points. The patients will be notified by e-mail of when it is
time to answer questionnaires. If they do not complete the
questionnaires they will be reminded by e-mail 7 days after
baseline and after 7 and 12 days after any of the observa-
tion points.
Data processing and analysis
The end points of the study will be evaluated according
to the intention-to-treat principle. In addition the com-
plier average causal effect will be analysed. Differences
between the intervention and the control group regard-
ing anxiety, depression, post-traumatic stress, health-
related quality of life and the presence and development
of these variables over time will be analysed using ana-
lysis of variance (ANOVA) with repeated measurements.
Should the variables not satisfy the basic assumptions of
normal distribution and equal variance, the Mixed re-
gression models will be used for analysis [43]. How and
to what extent the different parts of the Internet-based
system for psychosocial support are used will be analysed
using the data on the study participants’ activities re-
corded in the system. Qualitative content analysis [44]
will be used to analyse the content of the discussion for-
ums and diaries. We also plan to use computerized text
analysis. Appropriate methods to control for mass signifi-
cance will be used.
For process analyses of CBT, multiple regression ana-
lysis will be used. The health economic analyses will re-
late to the interventions’ cost-effectiveness compared
with the cost-effectiveness for standard care, which will
be analysed in the way that incremental costs are related to
the quality-adjusted life years (QALYs). The costs includedirect costs (e.g. medical care) and indirect costs (e.g. pro-
duction) as well as costs for patients, families and health
care and to the community. We will analyse the differences
between the groups in the short term, after 1, 4, 7,
10 months, and in the long term, after 18 and 24 months.
Health economic effects will be analysed after 10 and
24 months. Background variables, such as medical and
socio-demographic factors that could potentially function
as moderators or confounders, will be controlled for. Inter-
net use other than the IS will be monitored by a project-
specific questionnaire administered to both groups in order
to control for this potential confounder.
Ethical aspects
The project has been approved by the Regional Ethical
Review Board in Uppsala (Dnr 2012/003). Written in-
formed consent will be obtained from the participants
before inclusion. Extensive measures have been taken,
and will continue to be taken, to minimize the risk of in-
fringing activities and to ensure that study participants’
personal data cannot be linked to patient-reported data
by unauthorized persons. Study participants may at any
time terminate participation without giving any explan-
ation. The literature does not suggest that Internet-based
support interventions have any negative effects. Rather,
there is good reason to assume that different types of
Internet-based support and treatment with CBT may be ef-
fective for treatment of psychological problems. The main
ethical risk is including participants with a need for other
specialized medical care, such as those with severe depres-
sion. The baseline measurement is designed to minimize
that risk. All study participants will also have an established
contact with physicians in routine health care.
Discussion
Most cancer patients have the ability to handle the mental
strain that cancer can cause, but a significant proportion of
this group report anxiety and depressive symptoms that
need to be attended to. Previous support interventions in a
general cancer population have not shown convincing or
clinically significant effects [2,45]. A plausible explanation
is that only patients with elevated levels of psychological
distress are helped by the support. We will therefore con-
duct screening to identify those with clinically relevant
levels of distress in order to target the support to those
who need it.
Since it has been found that a significant portion of
this group do not take part in psychological support of-
fered, a stepwise approach will be used to individualize
the level of support needed. In addition, studies have
shown that some patients who report emotional distress
decline support because, among other reasons, they live
a long distance from the clinic. By offering support via
the Internet, we may reach a larger population. Studies
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fective as in vivo CBT and based on this knowledge it
can also be cost-effective to administer assistance via the
Internet since the therapist can treat more patients in
less time [46].
Internet-based stepped care and the impact of such
care for cancer patients with anxiety and depressive
symptoms has not been extensively studied previously.
There is a lack of controlled studies of the psychological
and behavioral processes involved in this type of inter-
vention for anxiety and depressive disorders. Since anx-
iety and depressive symptoms are relatively common in
patients with cancer and the availability of adequate sup-
port efforts is limited, there is a need to develop evidence-
based stepped care for patients with cancer, to be delivered
via the Internet.
To increase the reliability and opportunities to imple-
ment the Internet-based psychosocial support nation-
wide, the study will be carried out in several counties
and clinics across Sweden.
A limitation of the design of this study is possible selec-
tion bias due to the fact that Internet-based stepped care
may appeal more to younger patients and those with
computer skills. The study’s reliability can be questioned
for the same reason, especially since the design may ap-
peal more to patients with a higher educational level who
may be more used to extensive reading. There will also
be no blinding in the study and consequently the control
group may become under- or overtreated. Furthermore,
it should also be considered that the results of this inter-
vention may not be applicable to other countries owing
to cultural differences.
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